by G3 Group | News and Updates, Research
We’re excited to announce three groundbreaking research projects focused on accelerating answers for people living with Charcot Marie Tooth disease. These innovative studies push beyond traditional approaches, targeting the biology of CMT in bold new ways — with the... by Teresa Carroll | News and Updates, Research
New Physical Exercise study published in November, 2024 issue of the Journal of the Peripheral Nervous System The results of a TIN-sponsored study to determine the effects of exercise on the progression of CMT1X, using a mouse model of CMT1X, was first published as... by Teresa Carroll | Research
The laboratories of Rudolf Martini and Richard Stanley have previously reported the discovery of a novel biological pathway in the human immune system, which is turned on in response to injury in the peripheral nervous system. A biological messenger that is produced... by Teresa Carroll | Research
An immune modulatory off-label approach for treating CMT1X The Martini laboratory has also initiated a program of evaluating drugs approved for other diseases for their possible use in treating CMT. The principle being followed is that drugs with demonstrated positive... 
